Atlas Trials

Tuvusertib in Astrocytoma With ATRX Mutation

Clinical trial NCT07417761 · RECRUITING

Trial details

NCT number
NCT07417761
Sponsor
Grupo Español de Investigación en Neurooncología
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Astrocytoma
Start date
2025-12-19
Primary completion
2028-09-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.